A recent East Asian study investigating prevalence of 24 CHIP mutations in AF vs. non-AF healthy subjects found increased incidence of DNMT3A and TET2 mutations among AF individuals, and this was associated with more malignant AF and less favourable clinical outcomes such as heart failure, ischemic stroke and death [45]. This evidence concerns the gene TET2 and heart failure.